BR0308709A - Formulações em suspensão de hfa de um anidrato - Google Patents

Formulações em suspensão de hfa de um anidrato

Info

Publication number
BR0308709A
BR0308709A BR0308709-3A BR0308709A BR0308709A BR 0308709 A BR0308709 A BR 0308709A BR 0308709 A BR0308709 A BR 0308709A BR 0308709 A BR0308709 A BR 0308709A
Authority
BR
Brazil
Prior art keywords
hfa
anhydrate
suspension formulations
crystalline
formulations
Prior art date
Application number
BR0308709-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of BR0308709A publication Critical patent/BR0308709A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR0308709-3A 2002-03-28 2003-03-20 Formulações em suspensão de hfa de um anidrato BR0308709A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats
PCT/EP2003/002899 WO2003082244A2 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen eines anhydrats

Publications (1)

Publication Number Publication Date
BR0308709A true BR0308709A (pt) 2005-01-04

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308709-3A BR0308709A (pt) 2002-03-28 2003-03-20 Formulações em suspensão de hfa de um anidrato

Country Status (21)

Country Link
EP (1) EP1492498A2 (de)
JP (1) JP5147158B2 (de)
KR (1) KR101005717B1 (de)
CN (1) CN1642525A (de)
AU (1) AU2003221509B2 (de)
BR (1) BR0308709A (de)
CA (1) CA2479638C (de)
DE (1) DE10214264A1 (de)
EA (1) EA008610B1 (de)
EC (1) ECSP045322A (de)
HR (1) HRP20040890A2 (de)
IL (1) IL163696A0 (de)
ME (1) ME00246B (de)
MX (1) MXPA04009338A (de)
NO (1) NO20044004L (de)
NZ (1) NZ536030A (de)
PL (1) PL371295A1 (de)
RS (1) RS52481B (de)
UA (1) UA79776C2 (de)
WO (1) WO2003082244A2 (de)
ZA (1) ZA200405637B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540367A (ja) * 2005-05-02 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
WO2006117299A2 (en) * 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
CN114712337A (zh) * 2016-09-19 2022-07-08 墨西哥氟石股份公司 药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP4672143B2 (ja) * 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
JP2004512379A (ja) * 2000-10-31 2004-04-22 ベーリンガー　インゲルハイム　ファルマ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング　ウント　コンパニー　コマンディトゲゼルシャフト 新規医薬組成物
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
UA79776C2 (en) 2007-07-25
WO2003082244A2 (de) 2003-10-09
MXPA04009338A (es) 2005-01-25
EP1492498A2 (de) 2005-01-05
DE10214264A1 (de) 2003-10-16
AU2003221509A1 (en) 2003-10-13
NZ536030A (en) 2006-07-28
CN1642525A (zh) 2005-07-20
ME00246B (de) 2011-05-10
NO20044004L (no) 2004-10-05
EA008610B1 (ru) 2007-06-29
WO2003082244A3 (de) 2004-02-05
CA2479638A1 (en) 2003-10-09
ECSP045322A (es) 2005-01-28
CA2479638C (en) 2011-01-04
YU86004A (sh) 2006-08-17
HRP20040890A2 (en) 2005-06-30
IL163696A0 (en) 2005-12-18
PL371295A1 (en) 2005-06-13
MEP47308A (en) 2011-02-10
AU2003221509B2 (en) 2008-01-24
JP2005527550A (ja) 2005-09-15
KR101005717B1 (ko) 2011-01-05
ZA200405637B (en) 2005-07-27
JP5147158B2 (ja) 2013-02-20
EA200401159A1 (ru) 2005-04-28
RS52481B (sr) 2013-02-28
KR20040098022A (ko) 2004-11-18

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
MXPA04000507A (es) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y uso terapeutico.
PL367105A1 (en) Quinoline derivative having azolyl group and quinazoline derivative
BR0311771A (pt) Derivados de nonano e azabiciclo-octano com atividade inibitória da ddp-iv
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
MXPA06000716A (es) Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1.
SG165987A1 (en) Substituted benzoxazoles and analogues as estrogenic agents
DE602005005240D1 (de) 4'-C-substituierte 2-Haloadenosinderivate
BR0110955A (pt) Derivados de tropano úteis para a terapia
MX9304647A (es) 7-(sustituido)-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinas y metodo para su produccion.
NO20045235L (no) Tetrahydropyranylsyklopentyltetrahydropyridopyridinmodulatorer med kjemokinreseptoraktivitet
DE69823648D1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
MXPA04009162A (es) Derivados de piperidina u 8-aza-biciclo[3.2.1]oct-3-ilo empleados como moduladores de actividad del receptor de quimiocina (especialmente ccr5).
BR0308709A (pt) Formulações em suspensão de hfa de um anidrato
BR0308764A (pt) Formulações em suspensão hfa contendo um anticolinérgico
TW200606152A (en) Piperidine compound and process for preparing the same
TWI262921B (en) Selective antagonists of A2B adenosine receptors
WO2004055026A8 (en) Tetracyclic 3-substituted indoles having serotonin receptor affinity
ES2177583T3 (es) Nuevo compuesto tetraciclico.
AR086573A2 (es) Derivados de 5-(piridin-3-il)-1-azabiciclo[3,2,1]octano y octeno, su preparacion y su aplicacion en terapeutica
AU2003241907A1 (en) Tetrahydropyran derivative
DE60100539D1 (en) Tosylprolin-derivate als thymidylat-synthase inhibitoren
ATE247656T1 (de) Pyrazolo(1,5-a)triazine als crf antagonisten
MY139258A (en) Carbamoyl-type benzofuran derivatives
WO2003044877A3 (en) Light emitting device and compounds for use therein

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 9/12, A61K 31/46, A61P 11/06

Ipc: A61K 9/12 (2011.01), A61K 31/46 (2011.01), A61P 11

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]